# MS4A6A

## Overview
MS4A6A is a gene that encodes the protein membrane spanning 4-domains A6A, a member of the MS4A family characterized by four transmembrane domains. This protein is primarily expressed in the hematopoietic system, particularly in monocytes and macrophages, where it plays a crucial role in immune response regulation and cellular signaling. As a transmembrane protein, MS4A6A is involved in forming complexes with other MS4A proteins, contributing to the modulation of immune cell activation and anti-inflammatory responses. The gene has been implicated in various diseases, including glioma and Alzheimer's disease, where its expression levels correlate with disease progression and pathology. Despite its significant roles, the precise functions of MS4A6A in healthy human cells remain partially understood, necessitating further research to elucidate its contributions to immune regulation and disease mechanisms (Mattiola2021The; Liang2001Identification; Zhang2022MS4A6A).

## Structure
The MS4A6A protein is a member of the MS4A gene family, characterized by four transmembrane domains. These domains are highly conserved among MS4A proteins, suggesting a critical role in their function (Mattiola2021The; Liang2001Identification). The protein lacks amino-terminal signal sequences but contains hydrophobic regions that allow it to span the membrane multiple times (Liang2001Identification). The predicted molecular weight of MS4A6A is approximately 27 kDa (Liang2001Identification).

The MS4A6A protein shares 23-29% amino acid sequence identity with CD20, particularly in the first three transmembrane domains, which have conserved amino acid sequences (Liang2001Identification). The first and second transmembrane domains also show significant sequence identity with the human FcϵRIβ chain (Liang2001Identification). The N- and C-terminal cytoplasmic domains of MS4A6A are divergent and often Pro-rich, indicating potential variability in function (Liang2001Identification).

Alternative splicing of the MS4A6A gene can result in truncated protein variants, lacking the fourth transmembrane and cytoplasmic domains, which suggests structural diversity within the family (Liang2001Structural). These splice variants may influence the protein's localization and function.

## Function
The MS4A6A gene is part of the MS4A family, which encodes proteins involved in immune response regulation and cellular signaling. MS4A6A is primarily expressed in the hematopoietic compartment, particularly in monocytes and macrophages, where it plays a role in modulating immune cell activation (Mattiola2021The; SilvaGomes2021Differential). It is part of a macrophage-specific cluster of MS4A proteins, including MS4A4A and MS4A7, which are expressed on the surface of human macrophages and are involved in anti-inflammatory responses (Mattiola2021The). MS4A6A is highly expressed in alternatively activated macrophages, which are associated with anti-inflammatory functions, and its expression is regulated by anti-inflammatory hormones such as glucocorticoids (Mattiola2021The).

In terms of molecular processes, MS4A6A is involved in the regulation of the NLRP3 inflammasome, a key component of the immune response (Mattiola2021The). The protein is also implicated in the 'sensing' function of macrophages by interacting with pattern recognition receptors, contributing to type 1 immunity (Mattiola2021The). Despite its significant role in immune regulation, the specific function of MS4A6A in healthy human cells remains partially understood, with ongoing research needed to fully elucidate its contributions (SilvaGomes2021Differential).

## Clinical Significance
The MS4A6A gene has been implicated in several diseases, notably glioma and Alzheimer's disease (AD). In glioma, MS4A6A is upregulated, correlating with poor clinical outcomes and reduced effectiveness of adjuvant chemotherapy. Its expression is associated with immune suppression through myeloid leukocyte infiltration and is linked to oncogenic processes such as extracellular matrix remodeling and IL-17 and p53 signaling pathways. High MS4A6A expression is a significant prognostic factor for survival in glioma patients, independent of glioma grade (Zhang2022MS4A6A).

In Alzheimer's disease, variants in the MS4A6A gene, particularly the rs610932 polymorphism, have been associated with altered expression levels and increased AD risk. The minor allele of rs610932 is linked to lower MS4A6A expression and is less common in AD patients. Elevated MS4A6A expression in the brain is associated with more advanced AD pathology, including higher Braak tangle and plaque scores. The gene's expression in blood and brain regions like Brodmann's area 9 is linked to increased AD risk, suggesting that high levels of MS4A6A may be detrimental in AD pathology (Ramirez2016Common; Proitsi2014Alzheimer’s; Ma2014MS4A).

## Interactions
MS4A6A, a member of the membrane-spanning 4A (MS4A) gene family, is involved in various protein interactions that influence immune function. It is known to interact with other MS4A proteins, such as MS4A4A and MS4A7, forming homo- and heterocomplexes in human macrophages. These interactions have been confirmed through techniques like split-ubiquitin two-hybrid analysis and FLIM-FRET, indicating the formation of microdomains in lipid rafts of the plasma membrane (Mattiola2021The). 

MS4A6A is also associated with CD163, a marker of M2 macrophages, suggesting a role in macrophage infiltration and immune modulation in glioma patients (Zhang2022MS4A6A). The protein-protein interaction network suggests potential interactions with other proteins such as CD33 and ABCA7, which are related to macrophage infiltration and glioma progression (Zhang2022MS4A6A). 

In the context of Alzheimer's disease, MS4A6A interacts with genes like CLU and APOE, with interaction scores indicating potential involvement in pathways related to beta-amyloid formation and neurofibrillary tangle assembly (Abd2020Association). These interactions highlight MS4A6A's role in both immune response and disease pathology.


## References


[1. (Liang2001Identification) Yinghua Liang and Thomas F. Tedder. Identification of a cd20-, fcϵriβ-, and htm4-related gene family: sixteen new ms4a family members expressed in human and mouse. Genomics, 72(2):119–127, March 2001. URL: http://dx.doi.org/10.1006/geno.2000.6472, doi:10.1006/geno.2000.6472. This article has 100 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/geno.2000.6472)

[2. (Zhang2022MS4A6A) Chunyu Zhang, Haitao Liu, Yinqiu Tan, Yang Xu, Yuntao Li, Shiao Tong, Sheng Qiu, Qianxue Chen, Zhongzhou Su, Daofeng Tian, Wei Zhou, and Chunlong Zhong. Ms4a6a is a new prognostic biomarker produced by macrophages in glioma patients. Frontiers in Immunology, August 2022. URL: http://dx.doi.org/10.3389/fimmu.2022.865020, doi:10.3389/fimmu.2022.865020. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2022.865020)

[3. (Ramirez2016Common) Leslie M. Ramirez, Naira Goukasian, Shai Porat, Kristy S. Hwang, Jennifer A. Eastman, Sona Hurtz, Benjamin Wang, Nouchee Vang, Renee Sears, Eric Klein, Giovanni Coppola, and Liana G. Apostolova. Common variants in abca7 and ms4a6a are associated with cortical and hippocampal atrophy. Neurobiology of Aging, 39:82–89, March 2016. URL: http://dx.doi.org/10.1016/j.neurobiolaging.2015.10.037, doi:10.1016/j.neurobiolaging.2015.10.037. This article has 39 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.neurobiolaging.2015.10.037)

[4. (Ma2014MS4A) Jing Ma, Jin-Tai Yu, and Lan Tan. Ms4a cluster in alzheimer’s disease. Molecular Neurobiology, 51(3):1240–1248, July 2014. URL: http://dx.doi.org/10.1007/s12035-014-8800-z, doi:10.1007/s12035-014-8800-z. This article has 41 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12035-014-8800-z)

[5. (SilvaGomes2021Differential) Rita Silva-Gomes, Sarah N Mapelli, Marie-Astrid Boutet, Irene Mattiola, Marina Sironi, Fabio Grizzi, Federico Colombo, Domenico Supino, Silvia Carnevale, Fabio Pasqualini, Matteo Stravalaci, Rémi Porte, Andrea Gianatti, Constantino Pitzalis, Massimo Locati, Maria José Oliveira, Barbara Bottazzi, and Alberto Mantovani. Differential expression and regulation of ms4a family members in myeloid cells in physiological and pathological conditions. Journal of Leukocyte Biology, 111(4):817–836, August 2021. URL: http://dx.doi.org/10.1002/jlb.2a0421-200r, doi:10.1002/jlb.2a0421-200r. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jlb.2a0421-200r)

[6. (Proitsi2014Alzheimer’s) Petroula Proitsi, Sang Hyuck Lee, Katie Lunnon, Aoife Keohane, John Powell, Claire Troakes, Safa Al-Sarraj, Simon Furney, Hilkka Soininen, Iwona Kłoszewska, Patrizia Mecocci, Magda Tsolaki, Bruno Vellas, Simon Lovestone, and Angela Hodges. Alzheimer’s disease susceptibility variants in the ms4a6a gene are associated with altered levels of ms4a6a expression in blood. Neurobiology of Aging, 35(2):279–290, February 2014. URL: http://dx.doi.org/10.1016/j.neurobiolaging.2013.08.002, doi:10.1016/j.neurobiolaging.2013.08.002. This article has 45 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.neurobiolaging.2013.08.002)

[7. (Liang2001Structural) Yinghua Liang, Thomas R. Buckley, LiLi Tu, Scott D. Langdon, and Thomas F. Tedder. Structural organization of the human ms4a gene cluster on chromosome 11q12. Immunogenetics, 53(5):357–368, June 2001. URL: http://dx.doi.org/10.1007/s002510100339, doi:10.1007/s002510100339. This article has 73 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s002510100339)

[8. (Mattiola2021The) Irene Mattiola, Alberto Mantovani, and Massimo Locati. The tetraspan ms4a family in homeostasis, immunity, and disease. Trends in Immunology, 42(9):764–781, September 2021. URL: http://dx.doi.org/10.1016/j.it.2021.07.002, doi:10.1016/j.it.2021.07.002. This article has 45 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.it.2021.07.002)

[9. (Abd2020Association) Hanem G. Abd Elrahman, Abeer Ramadan, Eman M. Saleh, Alia A. Saleh, Noha A. Sabry, and Mohamed R. Mohamed. Association study of polymorphisms in abca7, clusterin, and ms4a6a genes with alzheimer’s disease in the egyptian population. Turkish Journal of Biochemistry, 45(6):757–765, November 2020. URL: http://dx.doi.org/10.1515/tjb-2020-0135, doi:10.1515/tjb-2020-0135. This article has 0 citations.](https://doi.org/10.1515/tjb-2020-0135)